115 related articles for article (PubMed ID: 31646834)
1. CA-125 might be good predictive tumor biomarker for earlier detection of serosal metastases including the ovarian metastasis in high-risk invasive lobular breast cancer.
Abduyev Z; Altundag K
J BUON; 2019; 24(4):1735. PubMed ID: 31646834
[No Abstract] [Full Text] [Related]
2. Sensitivity of breast and ovarian cancer cells for interferons (IFNs) and retinoids.
Daxenbichler G; Widschwendter M; Marth C
Ann N Y Acad Sci; 1996 Apr; 784():294-303. PubMed ID: 8651578
[No Abstract] [Full Text] [Related]
3. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
Goldstein NS
Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
[TBL] [Abstract][Full Text] [Related]
4. Morphological and phenotypical features of ovarian metastases in breast cancer patients.
Peters IT; van der Steen MA; Huisman BW; Hilders CG; Smit VT; Vahrmeijer AL; Sier CF; Trimbos JB; Kuppen PJ
BMC Cancer; 2017 Mar; 17(1):206. PubMed ID: 28327103
[TBL] [Abstract][Full Text] [Related]
5. Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics.
McCart Reed AE; Kutasovic JR; Lakhani SR; Simpson PT
Breast Cancer Res; 2015 Jan; 17(1):12. PubMed ID: 25849106
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I
Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963
[TBL] [Abstract][Full Text] [Related]
7. Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology.
Lishman SC; Lakhani SR
Histopathology; 1999 Sep; 35(3):195-200. PubMed ID: 10469210
[TBL] [Abstract][Full Text] [Related]
8. Uroplakin II Expression in Breast Carcinomas Showing Apocrine Differentiation: Putting Some Emphasis on Invasive Pleomorphic Lobular Carcinoma as a Potential Mimic of Urothelial Carcinoma at Metastatic Sites.
Tajima S; Koda K
Dis Markers; 2016; 2016():2940496. PubMed ID: 27642214
[TBL] [Abstract][Full Text] [Related]
9. A case of ovarian cancer with remote metastases, with emphasis on changes in tumor marker values.
Mikami M; Suzuki A; Takehara K; Komiyama S; Ishikawa M; Hirose T
Gynecol Oncol; 2003 Aug; 90(2):462-5. PubMed ID: 12893220
[TBL] [Abstract][Full Text] [Related]
10. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.
Park CK; Jung WH; Koo JS
Breast Cancer Res Treat; 2016 Aug; 159(1):55-69. PubMed ID: 27469595
[TBL] [Abstract][Full Text] [Related]
11. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
[TBL] [Abstract][Full Text] [Related]
12. Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles.
Voglstaetter M; Thomsen AR; Nouvel J; Koch A; Jank P; Navarro EG; Gainey-Schleicher T; Khanduri R; Groß A; Rossner F; Blaue C; Franz CM; Veil M; Puetz G; Hippe A; Dindorf J; Kashef J; Thiele W; Homey B; Greco C; Boucheix C; Baur A; Erbes T; Waller CF; Follo M; Hossein G; Sers C; Sleeman J; Nazarenko I
J Pathol; 2019 Aug; 248(4):421-437. PubMed ID: 30982971
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.
Kuroda H; Tamaru J; Takeuchi I; Ohnisi K; Sakamoto G; Adachi A; Kaneko K; Itoyama S
Virchows Arch; 2006 Apr; 448(4):500-5. PubMed ID: 16538444
[TBL] [Abstract][Full Text] [Related]
14. CA 15-3 (Mucin-1) and physiological characteristics of breast cancer from Lahore, Pakistan.
Begum M; Karim S; Malik A; Khurshid R; Asif M; Salim A; Nagra SA; Zaheer A; Iqbal Z; Abuzenadah AM; Alqahtani MH; Rasool M
Asian Pac J Cancer Prev; 2012; 13(10):5257-61. PubMed ID: 23244146
[TBL] [Abstract][Full Text] [Related]
15. Lower genital tract metastases at time of first diagnosis of mammary invasive lobular carcinoma.
Engelstaedter V; Mylonas I
Arch Gynecol Obstet; 2011 Mar; 283 Suppl 1():93-5. PubMed ID: 21293870
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature.
Jacobs M; Fan F; Tawfik O
Ann Diagn Pathol; 2012 Jun; 16(3):185-9. PubMed ID: 22197540
[TBL] [Abstract][Full Text] [Related]
17. Invasive lobular carcinoma and cytokeratin immunohistochemistry: an audit.
Chandler IP; Oommen R; Lawson CW
J Clin Pathol; 2003 Mar; 56(3):240. PubMed ID: 12610108
[No Abstract] [Full Text] [Related]
18. Fine-needle aspiration cytology samples: a good source of material for evaluating biomarkers in breast cancer.
Schmitt F; Vielh P
Histopathology; 2015 Jan; 66(2):314-5. PubMed ID: 24750212
[No Abstract] [Full Text] [Related]
19. PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages: An Assessment of 245 Primary and 40 Metastatic Tumors.
Dill EA; Gru AA; Atkins KA; Friedman LA; Moore ME; Bullock TN; Cross JV; Dillon PM; Mills AM
Am J Surg Pathol; 2017 Mar; 41(3):334-342. PubMed ID: 28195880
[TBL] [Abstract][Full Text] [Related]
20. Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases.
Manson QF; Schrijver WAME; Ter Hoeve ND; Moelans CB; van Diest PJ
Clin Exp Metastasis; 2019 Feb; 36(1):29-37. PubMed ID: 30547271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
